Skip to content

Steven Mark Abbadessa, D.O.

NPI 1881668564ActiveIndividual· Colon & Rectal Surgery· Saint Louis, MO

Opted out of Medicare from August 2018 to August 2028. Colon & Rectal Surgery (D.O.) in Saint Louis, Missouri, licensed in MO, with an NPI issued in February 2006. Part D covered 30 prescriptions written in 2024, 87% of them generic. Salix Pharmaceuticals, A Division of Bausch Health US, LLC reported $16.18 in payments in 2024, mostly food and beverage.

Overview

NPI1881668564
StatusActive
Entity typeIndividual
CredentialD.O.
Sole proprietorYes
NPI issuedFeb 17, 2006
Last updated in NPPESJun 21, 2019

Specialties and licenses

TaxonomyCodeLicenseState
Colon & Rectal Surgery Primary208C00000XR5J14MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026
Opt-outOpted out Aug 23, 2018 – Aug 23, 2028
Can order and referYes

During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.

Part D prescriptions in 2024

Prescriptions (claims)30 · 34 30-day fills
Patients17
Total drug cost$1,884
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$16.18 · 1 payment from 1 company

Top paying companies in 2024

What the 2024 payments were for

  • Food and Beverage$16.18 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Colon & Rectal Surgery providers in Saint Louis

All Colon & Rectal Surgery providers in Missouri →